Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 70 | 0 | 0 |
| Gross Profit | N/A | N/A | 70 | N/A | N/A |
| Operating Expenses | 3,187 | 3,576 | 6,718 | 9,722 | 9,126 |
| Operating Income | -3,187 | -3,576 | -6,648 | -9,722 | -9,126 |
| Interest Expense | 886 | 858 | 1,045 | 2,971 | 2,003 |
| Other Income | 364,647 | -346 | -513 | 17,369 | 611 |
| Pre-tax Income | 360,575 | -4,780 | -8,206 | 4,677 | -10,517 |
| Income Tax | 111,550 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 249,025 | -4,780 | -8,206 | 4,677 | -10,517 |
| Minority Interests | -255 | -256 | -303 | -418 | -1,126 |
| Net Income | $249,280 | $-4,524 | $-7,903 | $5,095 | $-9,391 |
| EPS Basic Total Ops | 0.59 | -0.01 | -0.02 | 0.01 | -0.03 |
| EPS Basic Continuous Ops | 0.59 | -0.01 | -0.02 | 0.01 | -0.03 |
| EPS Diluted Total Ops | 0.59 | -0.01 | -0.02 | 0.01 | -0.03 |
| EPS Diluted Continuous Ops | 0.59 | -0.01 | -0.02 | 0.01 | -0.03 |
| EPS Diluted Before Non-Recurring Items | 0.59 | 0.00 | 0.00 | -0.03 | -0.03 |
| EBITDA(a) | $-2,989 | $-254 | $-263 | $-3,622 | $-7,610 |